News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Boudes Pol F
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/03/2023 |
4
| Boudes Pol F (Director) has filed a Form 4 on Protalix BioTherapeutics, Inc.
Txns:
| Granted 61,676 options to buy
@ $1.66, valued at
$102.4k
|
|
01/30/2023 |
4
| Boudes Pol F (Chief Medical Officer) has filed a Form 4 on GALECTIN THERAPEUTICS INC
Txns:
| Granted 50,000 options to buy
@ $1.11, valued at
$55.5k
|
|
09/09/2022 |
4
| Boudes Pol F (Director) has filed a Form 4 on Protalix BioTherapeutics, Inc.
Txns:
| Granted 50,000 options to buy
@ $1.03, valued at
$51.5k
|
|
01/25/2022 |
4
| Boudes Pol F (Chief Medical Officer) has filed a Form 4 on GALECTIN THERAPEUTICS INC
Txns:
| Granted 50,000 options to buy
@ $1.98, valued at
$99k
|
|
03/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/22/2020 |
4
| Boudes Pol F (Director) has filed a Form 4 on Protalix BioTherapeutics, Inc.
Txns:
| Granted 40,000 options to buy
@ $3.55, valued at
$142k
|
|
01/31/2019 |
4
| Boudes Pol F (Chief Medical Officer) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 138,312 options to buy
@ $8.43, valued at
$1.2M
|
|
01/26/2018 |
4
| Boudes Pol F (Chief Medical Officer) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 125,000 options to buy
@ $11.69, valued at
$1.5M
|
|
01/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/28/2016 |
4
| Boudes Pol F (Chief Medical Officer) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 54,000 options to buy
@ $1.06, valued at
$57.2k
|
|
01/27/2015 |
4
| Boudes Pol F (Chief Medical Officer) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 75,000 options to buy
@ $10, valued at
$750k
|
|
04/16/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/06/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/17/2012 |
4
| Boudes Pol F (Chief Medical Officer) has filed a Form 4 on AMICUS THERAPEUTICS INC
Txns:
| Granted 60,000 options to buy
@ $6.45, valued at
$387k
|
|
06/20/2011 |
4
| Boudes Pol F (Chief Medical Officer) has filed a Form 4 on AMICUS THERAPEUTICS INC
Txns:
| Granted 85,000 options to buy
@ $6.06, valued at
$515.1k
|
|
06/17/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/17/2009 |
4
| Boudes Pol F (Chief Medical Officer) has filed a Form 4 on AMICUS THERAPEUTICS INC
Txns:
| Granted 80,000 options to buy
@ $4.16, valued at
$332.8k
|
|
02/05/2009 |
4
| Boudes Pol F (Chief Medical Officer) has filed a Form 4 on AMICUS THERAPEUTICS INC |
|
|